1-8 of 8
Huiqin Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

Free
Jeffrey S. Morris, Rajyalakshmi Luthra, Yusha Liu, Dzifa Y. Duose, Wonyul Lee, Neelima G. Reddy, Justin Windham, Huiqin Chen, Zhimin Tong, Baili Zhang, Wei Wei, Manyam Ganiraju, Bradley M. Broom, Hector A. Alvarez, Alicia Mejia, Omkara Veeranki, Mark J. Routbort, Van K. Morris, Michael J. Overman, David Menter, Riham Katkhuda, Ignacio I. Wistuba, Jennifer S. Davis, Scott Kopetz, Dipen M. Maru
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (1): 120–130.
https://doi.org/10.1158/1078-0432.CCR-20-2403
Published: 04 January 2021
View articletitled, Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting
Open the PDF for Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting in another window
Includes: Supplementary data
Journal Articles

Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer

Free
Funda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, Aysegul Sahin, Emily Tarco, Selin Carkaci, Beatriz E. Adrada, Gopal Singh, Kim-Anh Do, Zerzhinski M. Garces, Elizabeth Mittendorf, Gildy Babiera, Isabelle Bedrosian, Rosa Hwang, Savitri Krishnamurthy, William F. Symmans, Ana Maria Gonzalez-Angulo, Gordon B. Mills
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (14): 3870–3883.
https://doi.org/10.1158/1078-0432.CCR-13-1507
Published: 14 July 2014
View articletitled, Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer
Open the PDF for Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Weekly nab-Rapamycin in Patients with Advanced Nonhematologic Malignancies: Final Results of a Phase I Trial

Free
Ana M. Gonzalez-Angulo, Funda Meric-Bernstam, Sant Chawla, Gerald Falchook, David Hong, Argun Akcakanat, Huiqin Chen, Aung Naing, Siqing Fu, Jennifer Wheler, Stacy Moulder, Thorunn Helgason, Shaoyi Li, Ileana Elias, Neil Desai, Razelle Kurzrock
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19): 5474–5484.
https://doi.org/10.1158/1078-0432.CCR-12-3110
Published: 01 October 2013
View articletitled, Weekly nab-Rapamycin in Patients with Advanced Nonhematologic Malignancies: Final Results of a Phase I Trial
Open the PDF for Weekly nab-Rapamycin in Patients with Advanced Nonhematologic Malignancies: Final Results of a Phase I Trial in another window
Includes: Supplementary data
Journal Articles

Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer

Free
Takafumi Sangai, Argun Akcakanat, Huiqin Chen, Emily Tarco, Yun Wu, Kim-Anh Do, Todd W. Miller, Carlos L. Arteaga, Gordon B. Mills, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (20): 5816–5828.
https://doi.org/10.1158/1078-0432.CCR-12-1141
Published: 14 October 2012
View articletitled, Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer
Open the PDF for Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors

Free
Funda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, Kim-Anh Do, Takafumi Sangai, Farrell Adkins, Ana Maria Gonzalez-Angulo, Asif Rashid, Katherine Crosby, Mei Dong, Alexandria T. Phan, Robert A. Wolff, Sanjay Gupta, Gordon B. Mills, James Yao
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1777–1789.
https://doi.org/10.1158/1078-0432.CCR-11-2123
Published: 14 March 2012
View articletitled, PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors
Open the PDF for PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors in another window
Includes: Supplementary data
Journal Articles

Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer

Free
Ana M. Gonzalez-Angulo, Takayuki Iwamoto, Shuying Liu, Huiqin Chen, Kim-Anh Do, Gabriel N. Hortobagyi, Gordon B. Mills, Funda Meric-Bernstam, W. Fraser Symmans, Lajos Pusztai
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (4): 1109–1119.
https://doi.org/10.1158/1078-0432.CCR-11-2762
Published: 14 February 2012
View articletitled, Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer
Open the PDF for Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer

Free
Ana M. Gonzalez-Angulo, Kirsten M. Timms, Shuying Liu, Huiqin Chen, Jennifer K. Litton, Jennifer Potter, Jerry S. Lanchbury, Katherine Stemke-Hale, Bryan T. Hennessy, Banu K. Arun, Gabriel N. Hortobagyi, Kim-Anh Do, Gordon B. Mills, Funda Meric-Bernstam
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (5): 1082–1089.
https://doi.org/10.1158/1078-0432.CCR-10-2560
Published: 01 March 2011
View articletitled, Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer
Open the PDF for Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer in another window
Journal Articles

Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes

Free
Elizabeth A. Mittendorf, Yun Wu, Maurizio Scaltriti, Funda Meric-Bernstam, Kelly K. Hunt, Shaheenah Dawood, Francisco J. Esteva, Aman U. Buzdar, Huiqin Chen, Sameena Eksambi, Gabriel N. Hortobagyi, Jose Baselga, Ana M. Gonzalez-Angulo
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7381–7388.
https://doi.org/10.1158/1078-0432.CCR-09-1735
Published: 30 November 2009
View articletitled, Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes
Open the PDF for Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes in another window